A Forbes article reporting on the Swedish American Life Science Summit (SALSS) in Stockholm, which gathered global scientists and investors to discuss innovations in healthcare such as robotics, nanotechnology, and cancer research. The article highlights the shift in the pharmaceutical industry towards collaboration with startups and "impact investing" to address chronic diseases in an aging population, featuring insights from various industry leaders.
This document is a program page for the SALSS (Swedish-American Life Science Summit) 2017. It lists the schedule for the 'HealthTech Showroom', exhibiting partners (such as Elekta and CellInk), and details the 'Rising Star Award' featuring HKH Daniel, Prince of Sweden. It also lists the jury members for the award and various investors attending the 'SALSS Investor Forum'. The document bears a House Oversight stamp.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity